Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study.


Journal

Journal of neuromuscular diseases
ISSN: 2214-3599
Titre abrégé: J Neuromuscul Dis
Pays: Netherlands
ID NLM: 101649948

Informations de publication

Date de publication:
Historique:
pubmed: 20 12 2018
medline: 3 1 2020
entrez: 20 12 2018
Statut: ppublish

Résumé

Fatigue is a common complaint in spinal muscular atrophy (SMA). Fatigability is well described in ambulatory SMA but the relationship to perceived fatigue has not been evaluated. Understanding this relationship has proven challenging for most disorders. To assess the relationship of perceived fatigue to fatigability, function, and quality of life in SMA. Thirty-two participants with SMA (21.9% type 2, 78.1% type 3) were recruited. Perceived fatigue and fatigability, function, and quality of life were assessed using standardized questionnaires and assessments. Associations were analyzed using Pearson correlation coefficients (p = 0.05). Also, the effects of age, type, and ambulatory status were determined on perceived fatigue. All SMA participants reported fatigue. Perceived fatigue was not associated with function, quality of life, or fatigability in ambulatory SMA patients. Neither age, type, nor ambulatory status influenced perceived fatigue. Perceived fatigue can be quantified in SMA. Interestingly, perceived fatigue did not correlate with fatigability or function, suggesting that cognitive, homeostatic, or psychologic factors may be more relevant as co-morbid factors. Clinical trials targeting perceived fatigue in SMA should focus on these patient-reported assessments. A multilevel approach is required to separate the various mechanisms involved in perceived fatigue.

Sections du résumé

BACKGROUND BACKGROUND
Fatigue is a common complaint in spinal muscular atrophy (SMA). Fatigability is well described in ambulatory SMA but the relationship to perceived fatigue has not been evaluated. Understanding this relationship has proven challenging for most disorders.
OBJECTIVE OBJECTIVE
To assess the relationship of perceived fatigue to fatigability, function, and quality of life in SMA.
METHODS METHODS
Thirty-two participants with SMA (21.9% type 2, 78.1% type 3) were recruited. Perceived fatigue and fatigability, function, and quality of life were assessed using standardized questionnaires and assessments. Associations were analyzed using Pearson correlation coefficients (p = 0.05). Also, the effects of age, type, and ambulatory status were determined on perceived fatigue.
RESULTS RESULTS
All SMA participants reported fatigue. Perceived fatigue was not associated with function, quality of life, or fatigability in ambulatory SMA patients. Neither age, type, nor ambulatory status influenced perceived fatigue.
CONCLUSIONS CONCLUSIONS
Perceived fatigue can be quantified in SMA. Interestingly, perceived fatigue did not correlate with fatigability or function, suggesting that cognitive, homeostatic, or psychologic factors may be more relevant as co-morbid factors. Clinical trials targeting perceived fatigue in SMA should focus on these patient-reported assessments. A multilevel approach is required to separate the various mechanisms involved in perceived fatigue.

Identifiants

pubmed: 30562906
pii: JND180342
doi: 10.3233/JND-180342
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-117

Auteurs

Sally Dunaway Young (S)

Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Department of Rehabilitation and Regenerative Medicine, Columbia University Medical Center, New York, NY, USA.

Jacqueline Montes (J)

Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Department of Rehabilitation & Regenerative Medicine, Program in Physical Therapy, Columbia University, New York, NY.

Samantha S Kramer (SS)

Department of Neurology, Columbia University Medical Center, New York, NY, USA.

Bernadette Podwika (B)

Department of Rehabilitation & Regenerative Medicine, Program in Physical Therapy, Columbia University, New York, NY.

Ashwini K Rao (AK)

Department of Rehabilitation & Regenerative Medicine, Program in Physical Therapy, Columbia University, New York, NY.

Darryl C De Vivo (DC)

Department of Neurology, Columbia University Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH